MRC: research grant: applicant-led supports research teams pursuing discovery and early translational studies to understand human health and disease, improve diagnosis, advance treatment and prevent illness.
The opening date changed from 7 April to 12 October 2026, at 9:00am UK time. The uninvited-resubmission ban no longer includes submissions to non-UKRI funders, and application questions now allow you to indicate a charity co-funder.
MRC: new investigator research grant: applicant-led supports new investigators with discovery and early translational health research to understand disease and build independent research careers.
MRC: partnership grant: applicant-led supports research teams to build collaborative capabilities, shared resources and skills that underpin research and advance understanding of human health and disease.
UKRI translation: MRC proof of concept: stage two supports academic teams developing and testing medical interventions and research tools to address significant health needs and deliver patient benefit.
UKRI Translation: MRC Impact Acceleration Awards support academic researchers to test a high-risk development step for medical products or interventions, generating evidence to guide progress towards patient benefit.
UKRI Translation: MRC Proof of Concept: stage one supports academic teams developing and testing medical interventions and research tools to address significant health needs and advance patient benefit.